Sign In
Buy CRIS
$0.500
-0.0025 (-0.498%)
At Close: Jun 03, 2026
Curis to Release First Quarter 2020 Financial Results and Hold Conference Call on May 12, 2020
12:00pm, Tuesday, 05'th May 2020
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that the Company will release its first quarter 2
20 Healthcare Stocks Moving In Monday's Pre-Market Session
11:44am, Monday, 04'th May 2020Still strapped for resources, rural hospitals wary of state reopening
04:52pm, Friday, 24'th Apr 2020
Hospitals worry that as businesses reopen, they may compete for needed supplies and hospitals could be hit with a second wave of coronavirus cases.
Still strapped for resources, rural hospitals wary of state re-opening
01:01pm, Friday, 24'th Apr 2020
Hospitals worry that as businesses reopen, they may compete for needed supplies and hospitals could be hit with a second wave of coronavirus cases.
The Daily Biotech Pulse: Genmark Pre-Announces Q1 Outperformance, Sage to Eliminate 53% of Workforce, Keros IPO
11:53am, Wednesday, 08'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs April 7)
Dr.Reddy's Laboratories...
Curis to Present at 19th Annual Needham Virtual Healthcare Conference
12:00pm, Tuesday, 07'th Apr 2020
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that James Dentzer, President and Chief Executive
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
08:01pm, Friday, 03'rd Apr 2020
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that on April 1, 2020, the independent Compensati
Curis Reports Fourth Quarter and Year-End 2019 Financial Results and Provides Business Update
08:01pm, Thursday, 19'th Mar 2020
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today reported its financial results for the fourth quarter and y
Curis, Inc. to Host Earnings Call
06:30pm, Thursday, 19'th Mar 2020
NEW YORK, NY / ACCESSWIRE / March 19, 2020 / Curis, Inc. (NASDAQ:CRIS) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 19, 2020 at 4:30 PM East
A Detroit Gallery Is Giving Out Free Meals—and Artist-Designed Coloring Books—to Children While Schools Are Closed
01:00pm, Thursday, 19'th Mar 2020
The Library Street Collective is offering kids dinner and artist coloring books while Detroit public schools are closed.
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
12:00am, Thursday, 19'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 18)
Biomerica, Inc. (NASDAQ...
The Week Ahead In Biotech: COVID-19 Updates, Tapering Earnings Flow, Eton's Seizure Drug Review
01:55pm, Sunday, 15'th Mar 2020
The biopharma space bled along with the rest of the market and COVID-19 levered biotechs weren't spared either. Biogen Inc (NASDAQ: BIIB ) was in the news for all wrong reasons, as an employee confere
The Week Ahead In Biotech: COVID-19 Updates, Tapering Earnings Flow, Eton's Seizure Drug Review
12:00am, Sunday, 15'th Mar 2020
The biopharma space bled along with the rest of the market and COVID-19 levered biotechs weren't spared either.
Biogen Inc (NASDAQ: BIIB) was in the news for all wrong...
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 12.)
Masimo...
Curis to Release Fourth Quarter and Year-End 2019 Financial Results and Hold Conference Call on March 19, 2020
12:00pm, Thursday, 12'th Mar 2020
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that the Company will release its fourth quarter
